0001140361-14-036054.txt : 20140919 0001140361-14-036054.hdr.sgml : 20140919 20140919134142 ACCESSION NUMBER: 0001140361-14-036054 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140919 DATE AS OF CHANGE: 20140919 EFFECTIVENESS DATE: 20140919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc CENTRAL INDEX KEY: 0001395937 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320162505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-225032 FILM NUMBER: 141111683 BUSINESS ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 650 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-419-1400 MAIL ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 650 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0707 D LIVE 0001395937 Syndax Pharmaceuticals Inc 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA MASSACHUSETTS 02451 781-419-1400 DELAWARE None None Corporation true Arlene Morris 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Executive Officer Director John Pallies 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Executive Officer Luke Evnin, Ph.D. 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Kim Kamdar, Ph.D 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Fabrice Egros, Ph.D. 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Dennis Podlesak 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Ivor Royston 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Richard P Shea 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director George W Sledge, Jr. M.D. 400 Totten Pond Road Suite 110 Waltham MA MASSACHUSETTS 02451 Director Pharmaceuticals Decline to Disclose 06b false 2014-09-18 false true true false 0 5000000 4947480 52520 false 10 0 0 0 false Syndax Pharmaceuticals Inc /s/Arlene Morris Arlene Morris Chief Executive Officer 2014-09-18